Chronic unilateral anterior nodular scleritis with local inflammation of the ciliary body associated with the varicella-zoster virus

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

AIM: To analyze the etiopathogenesis, clinical features, and treatment algorithm for chronic unilateral anterior nodular scleritis with local inflammation of the ciliary body to increase medical alertness to the herpetic etiology of the disease in the absence of extraocular manifestations of herpes infection, reduce the disease duration, and increase the effectiveness of treatment.

RESULTS: Features of etiopathogenesis were analyzed. The characteristic clinical symptoms of chronic nodular scleritis, local anterior cyclitis, and pars planitis caused by the varicella-zoster virus (VZV) were described. The etiological role of VZV has been established based on high levels of VZV-IgG antibodies, presence of VZV-gE-IgG antibodies (markers of active virus replication), and effectiveness of antiherpetic therapy.

DISCUSSION: The surgical removal of a melanocytic skin nevus with skin autotransplantation in the paraorbital region of the left eye, in the zone of innervation of the first branch of the trigeminal nerve, contributed to the reactivation of the ophthalmic herpes and the development of anterior nodular scleritis of the left eye. An intensive long-term ineffective therapy with corticosteroids and antibacterial drugs in the absence of etiotropic treatment caused a chronic course of anterior nodular scleritis, spread of the inflammatory process to the ciliary body, and development of local anterior cyclitis and pars planitis of herpetic etiology in a 17-year-old child.

CONCLUSION: Maximum medical alertness and early and accurate clinical differential diagnosis between scleritis associated with immunoinflammatory rheumatic diseases and herpesvirus infections are necessary since the expansion of the range and number of anti-inflammatory drugs used in the absence of positive dynamics from their use leads to a chronic disease course, damage not only to deep layers of the sclera but also the spread of inflammation to the deeper layers of the eyeball, a decrease in visual acuity, undesirable effects of local glucocorticoid therapy, and an increase in intraocular pressure and development of cataracts. With any scleritis resistant to conventional treatment, the likelihood of a herpetic etiology of the inflammatory process and laboratory diagnosis of ophthalmic herpes should be considered. In the absence of a specialized laboratory, for etiological diagnosis, the possibility of ex juvantibus antiviral therapy should be considered. The described clinical symptoms of chronic nodular scleritis with local lesions of the ciliary body contribute to the early diagnosis of ophthalmoherpes, which allows the timely initiation of antiviral therapy with an antiherpetic effect, prevents the development of a chronic disease course, occurrence of complications, and preservation and/or restoration of visual acuity.

About the authors

Luydmila A. Kovaleva

Helmholtz National Medical Research Center of Eye Diseases

Author for correspondence.
Email: ulcer.64@mail.ru
ORCID iD: 0000-0001-6239-9553
SPIN-code: 1406-5609

MD, PhD

Russian Federation, Moscow

Galina I. Krichevskaya

Helmholtz National Medical Research Center of Eye Diseases

Email: ulcer.64@mail.ru
ORCID iD: 0000-0001-7052-3294
SPIN-code: 6808-0922

MD, PhD

Russian Federation, Moscow

Galina A. Davydova

Helmholtz National Medical Research Center of Eye Diseases

Email: ulcer.64@mail.ru
ORCID iD: 0000-0003-4215-7084
SPIN-code: 4895-7983

MD, PhD

Russian Federation, Moscow

Alina A. Zaitseva

Helmholtz National Medical Research Center of Eye Diseases

Email: ulcer.64@mail.ru
ORCID iD: 0000-0001-8852-3305

ophthalmologist

Russian Federation, Moscow

References

  1. Akpek EK, Thorne JE, Qazi FA, et al. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111(3):501–506. doi: 10.1016/j.ophtha.2003.06.006
  2. Okhravi N, Odufuwa B, McCluskey P, Lightman S. Scleritis. Surv Ophthalmol. 2005;50(4):351–363. doi: 10.1016/j.survophthal.2005.04.001
  3. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, et al. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012;119(1):43–50. doi: 10.1016/j.ophtha.2011.07.013
  4. Homayounfar G, Nardone N, Borkar DS, et al. Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study. Am J Ophthalmol. 2013;156(4):752–758. doi: 10.1016/j.ajo.2013.05.026
  5. Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60(3):163–191. doi: 10.1136/bjo.60.3.163
  6. Wieringa WG, Wieringa JE, ten Dam-van Loon NH, Los LI. Visual outcome, treatment results, and prognostic factors in patients with scleritis. Ophthalmology. 2013;120(2):379–386. doi: 10.1016/j.ophtha.2012.08.005
  7. Akintayo RO, Adelowo OO, Egajifo O, et al. The impact of ocular manifestations of rheumatoid arthritis on the health-related quality of life and the functional ability of black Africans. Int Ophthalmol. 2019;39(5):1003–1012. doi: 10.1007/s10792-018-0902-6
  8. Sharma SM, Damato E, Hinchcliffe AE, et al. Long-term efficacy and tolerability of TNFalpha inhibitors in the treatment of non-infectious ocular inflammation: an 8-year prospective surveillance study. Br J Ophthalmol. 2021;105(9):1256–1262. doi: 10.1136/bjophthalmol-2018-312767
  9. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, et al. Scleritis therapy. Ophthalmology. 2012;119(1):51–58. doi: 10.1016/j.ophtha.2011.07.043
  10. Heron E, Bourcier T. [Scleritis and episcleritis]. J Fr Ophtalmol. 2017;40(8):681–695. (in French) doi: 10.1016/j.jfo.2017.04.007
  11. Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, et al. Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases. Ophthalmology. 2012;119(7):1460–1464. doi: 10.1016/j.ophtha.2012.01.033
  12. Loureiro M, Rothwell R, Fonseca S. Nodular Scleritis Associated with Herpes Zoster Virus: An Infectious and Immune-Mediated Process. Case Rep Ophthalmol Med. 2016;2016:8519394. doi: 10.1155/2016/8519394

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Anterior nodular chronic scleritis, 7 months of treatment: а — local prominent edema, nodular infiltrate 4 mm in diameter, b — hyperemia of the bulbar conjunctiva with a violet tint.

Download (131KB)
3. Fig. 2. Local cyclitis, 7 months of treatment: а — fogging of the endothelium, multiple dust-like precipitates in the lower third of the cornea, b — аctive cells 1+ in the moisture of the anterior chamber.

Download (128KB)
4. Fig. 3. Local parsplanitis, 7 months of treatment: а — cellular detritus in the vitreous body in the form of “lumps of snow”; b — in the vitreous body, multiple aggregates of inflammatory cells.

Download (125KB)
5. Fig. 4. Ultrasound biomicroscopy of the outer quadrant of the left eye: a — local thickening of the sclera with a decrease in its echo density, 0.85 mm long and 5.43×6.31 mm in size; b — local thickening of the ciliary body up to 0.93 mm, with a decrease in its echogenicity.

Download (122KB)
6. Fig. 5. A local area of thinned sclera through which the brown plate (lamina fusca) of the sclera and the choroid are visible.

Download (90KB)

Copyright (c) 2022 Kovaleva L.A., Krichevskaya G.I., Davydova G.A., Zaitseva A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies